Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli.
about
Potential Use of Antimicrobial Peptides as Vaginal Spermicides/MicrobicidesThe Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer DrugsRole of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversalThe trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine but not trichloroacetate inhibits pathogen-stimulated TNF-α in human extraplacental membranes in vitroCationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureusBioprospecting the American alligator (Alligator mississippiensis) host defense peptidomeLL-37 via EGFR transactivation to promote high glucose-attenuated epithelial wound healing in organ-cultured corneas.Antimicrobial anxiety: the impact of stress on antimicrobial immunityHuman antimicrobial proteins in ear wax.Intramammary expression and therapeutic effect of a human lysozyme-expressing vector for treating bovine mastitis.An endoplasmic reticulum stress-initiated sphingolipid metabolite, ceramide-1-phosphate, regulates epithelial innate immunity by stimulating β-defensin productionA site-specific recombinase-based method to produce antibiotic selectable marker free transgenic cattleModulation of early β-defensin-2 production as a mechanism developed by type I Toxoplasma gondii to evade human intestinal immunityEdwardsiella tarda MliC, a lysozyme inhibitor that participates in pathogenesis in a manner that parallels Ivy.Combination of alpha-melanocyte stimulating hormone with conventional antibiotics against methicillin resistant Staphylococcus aureus.Antimicrobial protein and Peptide concentrations and activity in human breast milk consumed by preterm infants at risk of late-onset neonatal sepsis.Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated antimicrobial activities.Role of cytokine signaling in group B Streptococcus-stimulated expression of human beta defensin-2 in human extraplacental membranesInnate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretionsSignal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytesSynergistic anti-inflammatory activity of the antimicrobial peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37) in a three-dimensional co-culture model of gingival epithelial cells and fibroblastsHuman beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruptionIn vivo expression of antimicrobial peptides in atopic dermatitis.Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds.Interleukin 13 exposure enhances vitamin D-mediated expression of the human cathelicidin antimicrobial peptide 18/LL-37 in bronchial epithelial cells.Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitisIntracellular innate resistance to bacterial pathogens.Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis.Ocular surface expression and in vitro activity of antimicrobial peptides.Role of host-defence peptides in eye diseasesAntimicrobial peptide response to group B Streptococcus in human extraplacental membranes in culture.The role of antimicrobial peptides at the ocular surface.Modulation of corneal epithelial innate immune response to pseudomonas infection by flagellin pretreatmentAre cationic antimicrobial peptides also 'double-edged swords'?Edwardsiella tarda Ivy, a lysozyme inhibitor that blocks the lytic effect of lysozyme and facilitates host infection in a manner that is dependent on the conserved cysteine residueCCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tractStaphylococcus aureus nasal carriage and its contributing factors.'Hints' in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death.Microbiology of the skin and the role of biofilms in infection.Antimicrobial peptides: key components of the innate immune system.
P2860
Q26765450-7E57E0BC-DB4E-4037-9ABE-1974D576D4DBQ26801532-FE742CED-3E24-4937-98C8-E82F327A568AQ28116404-F12806F8-310D-42E8-94CA-2E0B260696AEQ28393746-DF1E12A4-A728-490D-9340-ED4F8CE7C5F1Q28395363-D865F216-FDC6-4D0B-91B5-80B7AE90023CQ28543378-03E3512E-9FBF-4E5B-97F7-D652AAE4D286Q33845085-1267A183-B10A-4B4E-9DEF-830F9811F3D3Q34015443-7C1E775D-2FC9-4F67-BBC5-B779F23CEFC9Q34025657-ACFF4CA3-474C-4953-BD7F-E4F212CB940CQ34565102-DB87AE65-FE36-49D7-B3D2-27D3BA330805Q34592824-02FA4D47-7EAA-45A6-8718-9C56A2A81C40Q34712517-F2F6BB7C-F392-4DB3-B8DD-6346D29DF974Q34931987-4B74C920-E357-4A1D-9612-91427D3A536EQ34955570-65716E83-EA2D-4068-8711-2398DAF941E0Q34989360-6391BA27-E505-497F-A436-501DDD0479C0Q35038781-2DFC7265-B42D-472E-86C5-E4843DF4BF61Q35047135-C0669414-773C-4356-829E-C29AED543F03Q35071362-51B52129-D409-4705-B1FA-817499A27E38Q35078336-5088DD85-B0A2-4179-8E6F-DF765DB560F7Q35220350-F900C9D6-40EE-453C-A536-78ABAAD83AB1Q35238104-177EEED5-B3E4-4764-9B72-22BB8EC7FE6BQ35635804-6D983235-36EE-4B4D-8EE2-ACACDBF056A7Q35744702-AFAC34C1-1EA8-4680-8324-14CF5B246F96Q35950558-30FD3A54-17E5-4853-8EBE-ECEA87C67B32Q36396765-37707B29-6EBD-43D2-B317-3616C574BFC5Q36422076-09CD9C77-8AAA-4CA8-B2F9-9EE56EB25275Q36580730-7C644D26-980F-4C08-A376-913090F20AEBQ36631071-A69AEBB6-DDFC-429E-94C4-B58C0B346363Q36726165-2E971115-E2D2-41E2-A28D-64F08093DCB3Q36799596-B4D9C201-3706-4355-AF19-4510922D32CDQ36877367-FB092685-6A51-4C07-9D0D-A01FCD56A43DQ37017370-8F7B9E0A-B48F-44F0-88EB-3DCD03D1A6D2Q37152330-D0D71B0B-8AF0-4D3F-AE51-7A9346F460E0Q37228731-CD4CA258-96A0-4561-B353-AD0707799A48Q37264699-4CA89A2B-2E71-49DD-B1D0-5D8F88AF2BC3Q37334297-15551144-FFE7-4B78-8160-E87EA88AE9A8Q37613669-25A6345F-D285-4C4A-82D8-74FBEFF5073CQ37741018-AEB1D009-D133-491C-A2A7-1D82D3A67E8EQ37942623-6270A449-BF2B-45B5-9BF1-70CFB2D0A859Q37954721-617982A1-490C-4FFC-983C-61D19AEFF588
P2860
Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Synergistic effect of antibact ...... s aureus and Escherichia coli.
@en
Synergistic effect of antibact ...... s aureus and Escherichia coli.
@nl
type
label
Synergistic effect of antibact ...... s aureus and Escherichia coli.
@en
Synergistic effect of antibact ...... s aureus and Escherichia coli.
@nl
prefLabel
Synergistic effect of antibact ...... s aureus and Escherichia coli.
@en
Synergistic effect of antibact ...... s aureus and Escherichia coli.
@nl
P2093
P1476
Synergistic effect of antibact ...... s aureus and Escherichia coli.
@en
P2093
Daiju Okuda
François Niyonsaba
Hideoki Ogawa
Hiroko Ushio
Isao Nagaoka
Ko Okumura
Shigaku Ikeda
Xuejun Chen
P304
P356
10.1016/J.JDERMSCI.2005.03.014
P577
2005-06-15T00:00:00Z